NO831361L - Fremgangsmaate ved fremstilling av terapeutisk aktive oxazolderivater. - Google Patents
Fremgangsmaate ved fremstilling av terapeutisk aktive oxazolderivater.Info
- Publication number
- NO831361L NO831361L NO831361A NO831361A NO831361L NO 831361 L NO831361 L NO 831361L NO 831361 A NO831361 A NO 831361A NO 831361 A NO831361 A NO 831361A NO 831361 L NO831361 L NO 831361L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- acceptable salt
- propionic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57066124A JPS58183676A (ja) | 1982-04-19 | 1982-04-19 | オキサゾ−ル誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO831361L true NO831361L (no) | 1983-10-20 |
Family
ID=13306807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO831361A NO831361L (no) | 1982-04-19 | 1983-04-18 | Fremgangsmaate ved fremstilling av terapeutisk aktive oxazolderivater. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4596816A (OSRAM) |
| EP (1) | EP0092239A3 (OSRAM) |
| JP (1) | JPS58183676A (OSRAM) |
| KR (1) | KR840004415A (OSRAM) |
| AU (1) | AU1355283A (OSRAM) |
| CA (1) | CA1195985A (OSRAM) |
| DK (1) | DK172183A (OSRAM) |
| ES (1) | ES521865A0 (OSRAM) |
| FI (1) | FI831253A7 (OSRAM) |
| GR (1) | GR79251B (OSRAM) |
| HU (1) | HU187002B (OSRAM) |
| NO (1) | NO831361L (OSRAM) |
| PT (1) | PT76563B (OSRAM) |
| ZA (1) | ZA832657B (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4632930A (en) * | 1984-11-30 | 1986-12-30 | E. I. Du Pont De Nemours And Company | Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives |
| ZW19786A1 (en) * | 1985-10-17 | 1988-05-18 | Hoffmann La Roche | Heterocyclic compounds |
| GB8531608D0 (en) * | 1985-12-23 | 1986-02-05 | Beecham Group Plc | Treatment |
| HU203330B (en) * | 1987-06-10 | 1991-07-29 | Pfizer | Process for producing oxazolidin-2-one derivatives and hypoglychemic pharmaceutical compositions containing them |
| US5239080A (en) * | 1989-02-08 | 1993-08-24 | Takeda Chemical Industries, Ltd. | Oxazole compounds and their use as antidiabetic and bone-reduction inhibitory agents |
| EP0440183A1 (en) * | 1990-02-01 | 1991-08-07 | Takeda Chemical Industries, Ltd. | Oxazole compounds, their production and use |
| FR2699172B1 (fr) * | 1992-12-11 | 1995-01-20 | Adir | Nouveaux dérivés de 4-méthyl-1,3-oxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| US6177452B1 (en) | 1996-04-03 | 2001-01-23 | Takeda Chemical Industries, Ltd. | Oxazole derivatives, their production and use |
| US6699896B1 (en) | 1998-05-12 | 2004-03-02 | Wyeth | Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| EP1077958A1 (en) * | 1998-05-12 | 2001-02-28 | American Home Products Corporation | Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| CA2330599A1 (en) * | 1998-05-12 | 1999-11-18 | Michael Sotirios Malamas | Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| AU2002246397B2 (en) | 2001-04-16 | 2005-03-24 | Tanabe Seiyaku Co., Ltd. | Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1226548A (OSRAM) * | 1967-06-14 | 1971-03-31 | Wyeth John & Brother Ltd | |
| GB1245087A (en) * | 1967-10-26 | 1971-09-02 | Wyeth John & Brother Ltd | Heterocyclic compounds |
| US3578671A (en) * | 1967-11-06 | 1971-05-11 | Wyeth John & Brother Ltd | Oxazoles |
-
1982
- 1982-04-19 JP JP57066124A patent/JPS58183676A/ja active Pending
-
1983
- 1983-04-12 CA CA000425700A patent/CA1195985A/en not_active Expired
- 1983-04-14 FI FI831253A patent/FI831253A7/fi not_active Application Discontinuation
- 1983-04-15 AU AU13552/83A patent/AU1355283A/en not_active Abandoned
- 1983-04-15 US US06/485,433 patent/US4596816A/en not_active Expired - Fee Related
- 1983-04-15 ZA ZA832657A patent/ZA832657B/xx unknown
- 1983-04-18 GR GR71110A patent/GR79251B/el unknown
- 1983-04-18 PT PT76563A patent/PT76563B/pt unknown
- 1983-04-18 NO NO831361A patent/NO831361L/no unknown
- 1983-04-19 EP EP83103787A patent/EP0092239A3/en not_active Withdrawn
- 1983-04-19 HU HU831358A patent/HU187002B/hu unknown
- 1983-04-19 DK DK172183A patent/DK172183A/da not_active IP Right Cessation
- 1983-04-19 ES ES521865A patent/ES521865A0/es active Granted
- 1983-11-16 KR KR1019830001606A patent/KR840004415A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| ZA832657B (en) | 1984-01-25 |
| DK172183D0 (da) | 1983-04-19 |
| AU1355283A (en) | 1983-10-27 |
| FI831253A0 (fi) | 1983-04-14 |
| HU187002B (en) | 1985-10-28 |
| FI831253L (fi) | 1983-10-20 |
| PT76563B (en) | 1986-05-07 |
| EP0092239A3 (en) | 1985-01-23 |
| DK172183A (da) | 1983-10-20 |
| FI831253A7 (fi) | 1983-10-20 |
| ES8603174A1 (es) | 1985-05-16 |
| EP0092239A2 (en) | 1983-10-26 |
| CA1195985A (en) | 1985-10-29 |
| KR840004415A (ko) | 1984-10-15 |
| JPS58183676A (ja) | 1983-10-26 |
| PT76563A (en) | 1983-05-01 |
| US4596816A (en) | 1986-06-24 |
| ES521865A0 (es) | 1985-05-16 |
| GR79251B (OSRAM) | 1984-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5299810B2 (ja) | 代謝疾患の治療に使用するための、化合物、薬学的組成物及び方法 | |
| NO831361L (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive oxazolderivater. | |
| JP5474769B2 (ja) | ペルオキシソーム増殖剤活性化受容体の活性化剤 | |
| WO2008030618A1 (en) | Benzo-fused compounds for use in treating metabolic disorders | |
| EP1924546A1 (en) | Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders | |
| IE890738L (en) | Hypoglycemic thiazolidinedione derivatives | |
| KR20090118958A (ko) | Ｐｐａｒ 활성 화합물 | |
| WO2001079197A1 (fr) | Activateurs de ppar$g(d) (peroxisome proliferator activated receptor $g(d)) | |
| NO327957B1 (no) | Substituert fenylpropansyrederivater som agonister for human peroksisom proliferantaktivert reseptor (PPAR)<alfa> | |
| FR2787789A1 (fr) | Benzopyranes et benzoxepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparations | |
| KR101942752B1 (ko) | Ｇｐｒ120 효능제로서의 티오아릴 유도체 | |
| WO2012136221A1 (en) | Ortho-fluoro substituted compounds for the treatment of metabolic diseases | |
| AU2013252205B2 (en) | 4-((substituted phenyl) difluoromethyl) phenoxy carboxylic acid derivative, and preparation method and uses thereof | |
| US5116855A (en) | Rhodanine derivatives and pharmaceutical compositions | |
| EP0096890B1 (en) | Oxazoleacetic acid derivatives, process for their production and compositions containing said derivatives | |
| SK137598A3 (en) | Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof | |
| KR20200008127A (ko) | 치환된 페닐아세트산 유도체의 제조방법 | |
| WO2005105764A1 (en) | Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof | |
| JP2000327603A (ja) | プロピオン酸誘導体の製造方法 | |
| US5489592A (en) | 3,4-dihydro-4-oxo-3-(2-propenyl)-1-phthalazineacetic acids and derivatives, their preparations and medicines containing them | |
| JPWO2006090920A1 (ja) | ペルオキシソーム増殖剤活性化受容体δの活性化剤 | |
| IE882015L (en) | PRIDYL-PYRROLO £1,2-c| THIAZOLES | |
| NO831094L (no) | Pyridon-2-derivater, fremgangsmaate til deres fremstilling, og legemidler inneholdende dem | |
| EP0313202A2 (en) | Process for preparing halomethyl thiazoles | |
| JPS59190979A (ja) | オキサゾ−ル誘導体の製造法 |